搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Escherichia coli O17:K52:H18 HTH-type transcriptional regulator hdfR (hdfR) CSB-YP483725EOG
CSB-EP483725EOG
CSB-BP483725EOG
CSB-MP483725EOG
CSB-EP483725EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 Probable UDP-N-acetyl-D-mannosaminuronic acid transferase (wecG) CSB-YP483726EOG
CSB-EP483726EOG
CSB-BP483726EOG
CSB-MP483726EOG
CSB-EP483726EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 Probable ubiquinone biosynthesis protein UbiB (ubiB), partial CSB-YP483727EOG1
CSB-EP483727EOG1
CSB-BP483727EOG1
CSB-MP483727EOG1
CSB-EP483727EOG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 Protein FdhD (fdhD) CSB-YP483728EOG
CSB-EP483728EOG
CSB-BP483728EOG
CSB-MP483728EOG
CSB-EP483728EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 Ferrous-iron efflux pump FieF (fieF), partial CSB-YP483729EOG1
CSB-EP483729EOG1
CSB-BP483729EOG1
CSB-MP483729EOG1
CSB-EP483729EOG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 50S ribosomal protein L31 (rpmE) CSB-YP483730EOG
CSB-EP483730EOG
CSB-BP483730EOG
CSB-MP483730EOG
CSB-EP483730EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 tRNA (uracil (54)-C (5))-methyltransferase CSB-YP483731EOG
CSB-EP483731EOG
CSB-BP483731EOG
CSB-MP483731EOG
CSB-EP483731EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 Thiazole synthase (thiG) CSB-YP483732EOG
CSB-EP483732EOG
CSB-BP483732EOG
CSB-MP483732EOG
CSB-EP483732EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 Isocitrate dehydrogenase kinase/phosphatase (aceK) CSB-YP483733EOG
CSB-EP483733EOG
CSB-BP483733EOG
CSB-MP483733EOG
CSB-EP483733EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 4-hydroxybenzoate octaprenyltransferase (ubiA), partial CSB-YP483734EOG1
CSB-EP483734EOG1
CSB-BP483734EOG1
CSB-MP483734EOG1
CSB-EP483734EOG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 60 kDa chaperonin (groL) CSB-YP483735EOG
CSB-EP483735EOG
CSB-BP483735EOG
CSB-MP483735EOG
CSB-EP483735EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 DNA mismatch repair protein mutL (mutL) CSB-YP483736EOG
CSB-EP483736EOG
CSB-BP483736EOG
CSB-MP483736EOG
CSB-EP483736EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 3-keto-L-gulonate-6-phosphate decarboxylase UlaD (ulaD) CSB-YP483737EOG
CSB-EP483737EOG
CSB-BP483737EOG
CSB-MP483737EOG
CSB-EP483737EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 Peptide methionine sulfoxide reductase MsrA (msrA) CSB-YP483738EOG
CSB-EP483738EOG
CSB-BP483738EOG
CSB-MP483738EOG
CSB-EP483738EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 Mannonate dehydratase (uxuA) CSB-YP483739EOG
CSB-EP483739EOG
CSB-BP483739EOG
CSB-MP483739EOG
CSB-EP483739EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 Peptide chain release factor 3 (prfC) CSB-YP483740EOG
CSB-EP483740EOG
CSB-BP483740EOG
CSB-MP483740EOG
CSB-EP483740EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 Probable phosphoglycerate mutase GpmB (gpmB) CSB-YP483741EOG
CSB-EP483741EOG
CSB-BP483741EOG
CSB-MP483741EOG
CSB-EP483741EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O7:K1 30S ribosomal protein S20 (rpsT) CSB-YP483742EON
CSB-EP483742EON
CSB-BP483742EON
CSB-MP483742EON
CSB-EP483742EON-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O7:K1 Carnitine operon protein CaiE (caiE) CSB-YP483743EON
CSB-EP483743EON
CSB-BP483743EON
CSB-MP483743EON
CSB-EP483743EON-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O7:K1 Protein fixA (fixA) CSB-YP483744EON
CSB-EP483744EON
CSB-BP483744EON
CSB-MP483744EON
CSB-EP483744EON-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>